UPDATE: Piper Sandler Upgrades Pacific Biosciences of California (PACB) to Overweight

Pre-Open Stock Movers 02/10: (TLRY) (GMDA) (CMLF) Higher; (VNRX) (CPST) (XONE) Lower (more...)

Pre-Open Stock Movers:

Tilray, Inc. (NASDAQ: TLRY) 53.5% HIGHER; adds to recent momentum gains.

Gamida Cell Ltd. (Nasdaq: GMDA) 49.5% HIGHER; announced the results of a Phase 3 clinical study of omidubicel presented in an oral session at the Transplantation & Cellular Therapy Meetings of the American Society of Transplantation and Cellular Therapy (ASTCT) and Center for International Blood & Marrow Transplant Research (CIBMTR), or the TCT Meetings. Omidubicel is an... More

Pacific Biosciences (PACB) Stock Explodes 21% As SoftBank Invests $900 Million, Analysts Positive

SoftBank said it will invest $900 million into Pacific Biosciences (NASDAQ: PACB) company, which develops and manufactures systems for gene sequencing. The investment will be made in the form of convertible senior notes.

The US-based company, which is commonly known as PacBio, will use the funds to help accelerate the commercialization of the companys technology and invest in future growth initiatives.

SoftBank will pay $43.50 per share, which is a 10% premium on the PACBs closing price on February 09.

This strategic investment by SoftBank validates our leadership position in the long-read DNA... More

SoftBank to invest $900 million in gene sequencing firm Pacific Biosciences

(Reuters) - SoftBank Group Corp will invest $900 million in gene sequencing firm Pacific Biosciences of California Inc in its latest healthcare investment, the company said on Wednesday.

(Reporting by Dania Nadeem in Bengaluru; Editing by Shinjini Ganguli)

Pacific Bio (PACB) Confirms $900 Million Investment from SoftBank

Pacific Biosciences of California, Inc. (NASDAQ: PACB) (the Company), a leading provider of high-quality, long-read sequencing platforms, today announced that SB Management, a subsidiary of Softbank Group Corp., will make an investment of $900 million in convertible senior notes to support the Companys future growth initiatives.

This strategic investment by SoftBank validates our leadership position in the long-read DNA sequencing market and enables us to further accelerate our growth strategies, said Christian Henry, President and Chief Executive Officer... More

SoftBank plans to make a $900 million investment in Pacific Bio (PACB) - WSJ

SoftBank plans to make a $900 million investment in Pacific Bio (NASDAQ: PACB) - WSJ